Background/objectives: Melasma is a common pigmentary disorder for which oral tranexamic acid has shown some efficacy in previous studies. The aim of this study was to assess the effectiveness of oral tranexamic acid in combination with hydroquinone cream in the treatment of melasma.
Methods: Subjects with moderate-to-severe melasma were enrolled. Group A received hydroquinone 4% cream, sunscreen and oral tranexamic acid, while Group B received hydroquinone 4% cream, sunscreen and placebo capsules for 3 months. All subjects had an additional 3-month follow-up visit on sunscreen alone. The primary outcome measure was change in modified Melasma Area and Severity Index (mMASI) score. In addition, the melanin index was measured using a mexameter.
Results: Fifty subjects were enrolled, and all completed the study. There was a 55% reduction in mMASI after 3 months from mean 8.96 (SD 2.45) to 4.0 (SD 1.6) in Group A compared to 10.9% from mean 8.53 (SD 2.04) to 7.6 (SD 2.0) in Group B. Three months after oral and topical therapy was discontinued, there was a 42% decrease in mMASI compared to baseline in Group A (mean 5.1 SD 1.7) vs. 4.7% in Group B (mean 8.1 SD 2.0). No serious adverse events were observed.
Conclusions: A combination of oral tranexamic acid and topical hydroquinone is more effective than hydroquinone alone in the treatment of melasma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajd.13267 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing Use and Familiarity of Enhanced Recovery After Surgery Elements in Pediatric Orthognathic Surgery.
J Craniofac Surg
October 2024
Department of Plastic Surgery, University of California, Irvine.
Enhanced recovery after surgery (ERAS) protocols have informed perioperative care across multiple surgical specialties, optimizing patient outcomes through surgical stress management and accelerated recovery. This study evaluates the familiarity and adoption of ERAS elements among craniofacial and oral and maxillofacial surgeons in pediatric orthognathic surgery, a field where a formal ERAS protocol has not been established. A closed-ended survey of 102 surgeons was conducted to assess familiarity with and utilization of 14 ERAS elements.
View Article and Find Full Text PDFTranexamic Acid in Symptomatic Chronic Subdural Hematoma in the Absence of Surgical Intervention.
Neurol India
November 2024
Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education (MAHE) Manipal, Karnataka, India.
Background: Standard treatment for symptomatic chronic subdural hematoma (CSDH) is a burr-hole evacuation. However, in patients in whom surgical evacuation carries a very high risk, we do not have an established practice guideline.
Objective: To analyze the outcome of symptomatic CSDH treated only by tranexamic acid.
Hereditary hemorrhagic telangiectasia: A pediatric-focused review.
Semin Pediatr Neurol
December 2024
Department of Pediatrics, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, United States. Electronic address:
Clinical manifestations of hereditary hemorrhagic telangiectasia (HHT) include vascular malformations of the skin, nasal mucosa, gastrointestinal tract, lungs, liver and central nervous system. These malformations range from punctate telangiectasias to larger arteriovenous malformations within visceral organs and the central nervous system. Vascular malformations increase risk for acute and chronic bleeding, anemia, as well secondary complications related to arterial-venous shunting.
View Article and Find Full Text PDFTranexamic Acid is Associated With Reduced Blood Loss and Transfusion Requirement in Pediatric Midface Reconstruction.
J Oral Maxillofac Surg
November 2024
Director, Jaw Deformities Care Program, Attending Surgeon, Division of Plastic and Maxillofacial Surgery, Children's Hospital Los Angeles, Los Angeles, CA; Director, Jaw Deformities Care Program, Attending Surgeon, Division of Plastic and Reconstructive Surgery, Keck School of Medicine of USC, Los Angeles, CA. Electronic address:
Article Synopsis
- The study investigates the effects of tranexamic acid (TXA) on blood loss and transfusion needs during midface reconstruction surgeries, given the significant risks of bleeding in these procedures.
- Conducted at Children's Hospital Los Angeles from 2010 to 2023, the retrospective cohort study analyzed data from 80 patients, categorizing them based on whether they received TXA or not.
- Key outcomes measured included intraoperative blood loss, transfusion requirements, complications, and length of hospital stay, with a focus on determining any statistically significant differences linked to TXA administration.
Tranexamic acid in endoscopic sinus surgery: an updated systematic review and meta-analysis of randomized controlled trials.
Eur Arch Otorhinolaryngol
November 2024
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Article Synopsis
- The study conducted a meta-analysis to assess the effectiveness and safety of tranexamic acid (TXA) during endoscopic sinus surgery by analyzing data from 23 randomized controlled trials involving 1,597 patients.
- TXA significantly reduced intraoperative blood loss, decreased operating time, and improved surgical field quality and surgeon satisfaction compared to control groups, with no reported thromboembolic events.
- Despite the positive results, the findings were affected by significant variations in study quality and heterogeneity among the included trials.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!